{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:36:16Z","timestamp":1790807776142,"version":"4.1.0"},"reference-count":49,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2015,10,3]]},"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Ampullary carcinomata (AC) can be separated into intestinal (IT) or pancreatobiliary (PB) subtypes. Although morphological, immunohistochemical and molecular differentiation of IT and PB have been well documented; the prognostic significance of histological subtype and whether patients with either subtype benefit from differential chemotherapeutic regimens remains unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>As part of a larger cohort study, patients who underwent resection for AC or pancreatic ductal adenocarcinoma (PDAC) were retrospectively identified. Clinicopathological covariates and outcome were obtained and MUC1, MUC2, CDX2 and CK20 were assessed with immunohistochemistry.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 99 ACs, the resultant immunophenotypes indicated 48% and 22% were IT and PB, respectively. Thirty (30%) cases were quadruple negative (QN). Within the PDAC cohort (N=257), the most prevalent immunophenotype was QN (53%). Subsequently, all QN ACs were classified as PB immunohistochemically yielding 47.5% and 52.5% classified as IT and PB, respectively. Involved regional lymph nodes and elevated T-stage were significantly associated with PB compared with IT AC (p=0.0032 and 0.0396, respectively). Progression-free survival revealed inferior survival for PB versus IT AC (p=0.0156).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>AC can be classified into prognostic groups with unique clinicopathological characteristics using immunohistochemistry. Immunophenotypical similarity of PB and PDAC suggests that treatment regimens similar to those used in PDAC should be explored.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jclinpath-2015-203337","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T22:18:43Z","timestamp":1445638723000},"page":"431-439","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups"],"prefix":"10.1136","volume":"69","author":[{"given":"Joyce M","family":"Leo","sequence":"first","affiliation":[{"name":"Division of Anatomic Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada"},{"name":"The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E","family":"Kalloger","sequence":"additional","affiliation":[{"name":"The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Pancreas Centre BC, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata D","family":"Peixoto","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia S","family":"Gale","sequence":"additional","affiliation":[{"name":"Anatomical Pathology, BC Cancer Agency, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L","family":"Webber","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada"},{"name":"The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Pancreas Centre BC, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Owen","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada"},{"name":"The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Pancreas Centre BC, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Renouf","sequence":"additional","affiliation":[{"name":"The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Pancreas Centre BC, Vancouver, British Columbia, Canada"},{"name":"Division of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F","family":"Schaeffer","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada"},{"name":"The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Pancreas Centre BC, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,10,23]]},"reference":[{"key":"2025092503395912000_69.5.431.1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199807000-00013"},{"key":"2025092503395912000_69.5.431.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-004-7498-x"},{"key":"2025092503395912000_69.5.431.3","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800810512"},{"key":"2025092503395912000_69.5.431.4","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199705000-00015"},{"key":"2025092503395912000_69.5.431.5","doi-asserted-by":"publisher","DOI":"10.1002\/jso.22090"},{"key":"2025092503395912000_69.5.431.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6109(05)70142-0"},{"key":"2025092503395912000_69.5.431.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1994.tb02077.x"},{"key":"2025092503395912000_69.5.431.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(85)80018-6"},{"key":"2025092503395912000_69.5.431.9","doi-asserted-by":"publisher","DOI":"10.1136\/gut.22.12.1031"},{"key":"2025092503395912000_69.5.431.10","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880401)61:7<1403::AID-CNCR2820610721>3.0.CO;2-S"},{"key":"2025092503395912000_69.5.431.11","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609006414"},{"key":"2025092503395912000_69.5.431.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1988.tb01926.x"},{"key":"2025092503395912000_69.5.431.13","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.12.1558"},{"key":"2025092503395912000_69.5.431.14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s004230100234","article-title":"Adenoma of the papilla and ampulla--premalignant lesions?","volume":"386","author":"Wittekind","year":"2001","journal-title":"Langenbecks Arch Surg Dtsch Ges F\u00fcr Chir"},{"key":"2025092503395912000_69.5.431.15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00534-004-0894-7","article-title":"Neoplastic diseases of the papilla of Vater","volume":"11","author":"Kimura","year":"2004","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"2025092503395912000_69.5.431.16","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200407000-00005"},{"key":"2025092503395912000_69.5.431.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-006-1166-5"},{"key":"2025092503395912000_69.5.431.18","first-page":"139","article-title":"Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study","volume":"14","author":"Agoff","year":"2001","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"2025092503395912000_69.5.431.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0242-6498(04)93977-6"},{"key":"2025092503395912000_69.5.431.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.05.003"},{"key":"2025092503395912000_69.5.431.21","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000149708.12335.6a"},{"key":"2025092503395912000_69.5.431.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065144"},{"key":"2025092503395912000_69.5.431.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2008.01.028"},{"key":"2025092503395912000_69.5.431.24","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-009-1080-7"},{"key":"2025092503395912000_69.5.431.25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-170"},{"key":"2025092503395912000_69.5.431.26","first-page":"1641","article-title":"The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis","volume":"54","author":"Roh","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"2025092503395912000_69.5.431.27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.7352"},{"key":"2025092503395912000_69.5.431.28","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181983ef7"},{"key":"2025092503395912000_69.5.431.29","unstructured":"Cubilla AL , Fitzgerald PJ . Tumors of the exocrine pancreas. Washington, D.C.: Armed Forces Institute of Pathology, 1984."},{"key":"2025092503395912000_69.5.431.30","first-page":"272","article-title":"Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases","volume":"16","author":"McCarthy","year":"2003","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"2025092503395912000_69.5.431.31","doi-asserted-by":"publisher","DOI":"10.1186\/gm357"},{"key":"2025092503395912000_69.5.431.32","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2012-0418-OA"},{"key":"2025092503395912000_69.5.431.33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s004230100232","article-title":"Carcinogenesis of cancer of the papilla and ampulla: pathophysiological facts and molecular biological mechanisms","volume":"386","author":"Esposito","year":"2001","journal-title":"Langenbecks Arch Surg Dtsch Ges F\u00fcr Chir"},{"key":"2025092503395912000_69.5.431.34","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990815)86:4<596::AID-CNCR8>3.0.CO;2-H"},{"key":"2025092503395912000_69.5.431.35","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-004-0898-3"},{"key":"2025092503395912000_69.5.431.36","doi-asserted-by":"publisher","DOI":"10.1136\/mp.56.6.336"},{"key":"2025092503395912000_69.5.431.37","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19961104)68:3<305::AID-IJC7>3.0.CO;2-5"},{"key":"2025092503395912000_69.5.431.38","first-page":"1841","article-title":"Cancers of the papilla of vater: mutator phenotype is associated with good prognosis","volume":"3","author":"Achille","year":"1997","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"2025092503395912000_69.5.431.39","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0444-1"},{"key":"2025092503395912000_69.5.431.40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.2003.01534.x"},{"key":"2025092503395912000_69.5.431.41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1200\/jco.2011.29.4_suppl.204","article-title":"Comparison of ampullary adenocarcinomas and duodenal adenocarcinomas with regard to clinical outcomes and responsiveness to fluoropyrimidine-based chemotherapy","volume":"29","author":"Overman","year":"2011","journal-title":"J Clin Oncol"},{"key":"2025092503395912000_69.5.431.42","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v4.i3.60"},{"key":"2025092503395912000_69.5.431.43","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2011.610006"},{"key":"2025092503395912000_69.5.431.44","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt191"},{"key":"2025092503395912000_69.5.431.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908721"},{"key":"2025092503395912000_69.5.431.46","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000230"},{"key":"2025092503395912000_69.5.431.47","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt540"},{"key":"2025092503395912000_69.5.431.48","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2603-0"},{"key":"2025092503395912000_69.5.431.49","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e3283378eb0"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2015-203337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:40:08Z","timestamp":1758796808000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2015-203337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,23]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,4,20]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1136\/jclinpath-2015-203337"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2015-203337","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,23]]}}}